Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Short chain Dehydrogenase. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114574454B details enzymatic synthesis for Tenofovir intermediates. Discover cost-effective, scalable biocatalytic solutions for pharmaceutical manufacturing.
Patent CN113293152B details short-chain dehydrogenase mutants for asymmetric reduction. This report analyzes cost reduction in chiral alcohol manufacturing and supply chain reliability for global buyers.
Patent CN108570460B discloses novel SDR mutants enabling high-selectivity biocatalytic reduction of acetophenone derivatives, offering a greener alternative for pharmaceutical intermediate manufacturing.